Alexion Pharmaceuticals, Inc. ALXN

Alexion Pharmaceuticals, Inc. Operating Cycle 2011-2026 | ALXN

Annual Operating Cycle Alexion Pharmaceuticals, Inc.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
12.8	-	278	578	595	293	325	331	335	335	-

All numbers in USD currency

Maximum	Minimum	Average
595	12.8	343

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
ANI Pharmaceuticals ANIP	295	$ 80.34	-	$ 1.55 B	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Aptorum Group Limited APM	4.89	$ 0.84	1.96 %	$ 4.58 M	China
I-Mab IMAB	271	-	-	$ 866 M	China
Adagene ADAG	53.8	$ 2.67	-	$ 150 M	China
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Akebia Therapeutics AKBA	166	$ 1.5	-	$ 281 M	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Compugen Ltd. CGEN	60.8	$ 1.71	-	$ 153 M	Israel
Amneal Pharmaceuticals AMRX	123	$ 14.52	-	$ 4.49 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel